Report from the NASPGN Therapeutics Subcommittee. Cisapride and the attack of the P-450s.
Shulman
R J
RJ
Children's Nutrition Research Center, Houston, Texas, USA.
D000897:Anti-Ulcer Agents; D002648:Child; D002927:Cimetidine / Q000493:pharmacokinetics; D020117:Cisapride; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D004347:Drug Interactions; D005764:Gastroesophageal Reflux / Q000188:drug therapy; D006801:Humans; D010880:Piperidines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011899:Ranitidine / Q000493:pharmacokinetics
D000897:Anti-Ulcer Agents; D010880:Piperidines; D002927:Cimetidine; D011899:Ranitidine; D003577:Cytochrome P-450 Enzyme System; D020117:Cisapride